Bli medlem
Bli medlem

Du är här

2019-05-09

Medivir: Redeye initiates coverage of Medivir

We are initiating coverage of Medivir with a base case fair value of
SEK 29. With an experienced management team, a deep clinical pipeline
and multiple catalysts over the next 12 months, the share offers
great potential for a significant rerating as the assets become
de-risked.

Read more and download the research update: http://bit.ly/2Lz65V9

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment
Banking. https://www.redeye.se/about/

-----------------------------------------------------------
https://news.cision.com/se/medivir/r/redeye-initiates-coverage-of-medivi...

Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.